{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:16Z","timestamp":1793731036931,"version":"4.6.1"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the prognostic value of efferocytosis-related biomarkers in PDAC and elucidate their underlying mechanisms, providing insights for personalized therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated bulk and single-cell transcriptomic data from public database to construct and validate an efferocytosis-related prognostic model for PDAC. Additionally, we analyzed the specimens from a cohort of 81 PDAC patients alongside cell experiments to elucidate the function of P2RY6. RNA-seq analysis was employed to uncover the effector pathways mediated by P2RY6.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      An efferocytosis-based prognostic model, EFFscore, developed based on\n                      <jats:italic>ADAM9<\/jats:italic>\n                      ,\n                      <jats:italic>P2RY6<\/jats:italic>\n                      , and\n                      <jats:italic>CD36<\/jats:italic>\n                      , can effectively assess the tumor phenotype of PDAC patients. The EFFscore is strongly associated with tumor evolution, malignant biological characteristics and microenvironmental interactions of PDAC. The essential mediator P2RY6 is significantly upregulated in PDAC tissue and cells, correlating closely with poor prognosis. Functional studies demonstrate that P2RY6 inhibition exhibits tumor-suppressive effects by activating the endoplasmic reticulum stress and enhancing anti-tumor immune responses. The P2RY6 receptor inhibitor, MRS-2578, emerges as a promising therapeutic candidate for PDAC treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prognostic model EFFscore exhibits remarkable predictive performance, accurately reflecting the malignant potential of PDAC. P2RY6 serves as a key oncogenic factor driver in PDAC, its targeted inhibition significantly suppresses tumor progression, highlighting its dual potential as a diagnostic biomarker and therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1708441","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:31:44Z","timestamp":1764138704000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiangjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puxiongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217350","article-title":"Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy","volume":"610","author":"Yu","year":"2025","journal-title":"Cancer Lett"},{"key":"B6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the anti-tumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12964-020-00542-9","article-title":"Regulation of efferocytosis as a novel cancer therapy","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e002548","DOI":"10.1136\/jitc-2021-002548","article-title":"S100A4 enhances protumor macrophage polarization by control of PPAR-\u03b3-dependent induction of fatty acid oxidation","volume":"9","author":"Liu","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e009318","DOI":"10.1136\/jitc-2024-009318","article-title":"Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS\/STING pathway","volume":"12","author":"Hou","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00731-2","article-title":"Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis","volume":"5","author":"Astuti","year":"2024","journal-title":"Nat Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01642-7","article-title":"Depletion of slow-cycling PDGFR\u03b1+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis","volume":"24","author":"Di Carlo","year":"2023","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115540","article-title":"Efferocytosis: An accomplice of cancer immune escape","volume":"167","author":"Qiu","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228781","article-title":"Purinergic signaling in pancreas\u2014From physiology to therapeutic strategies in pancreatic cancer","volume":"21","author":"Novak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071595","article-title":"Microglia purinoceptor P2Y6: an emerging therapeutic target in CNS diseases","volume":"9","author":"Anwar","year":"2020","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00210","article-title":"Discovery of selective P2Y6R antagonists with high affinity and in vivo efficacy for inflammatory disease therapy","volume":"66","author":"Zhu","year":"2023","journal-title":"J Med Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad796","article-title":"Macrophage P2Y6 receptor deletion attenuates atherosclerosis by limiting foam cell formation through phospholipase C\u03b2\/store-operated calcium entry\/calreticulin\/scavenger receptor A pathways","volume":"45","author":"Li","year":"2024","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00771-8","article-title":"Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance","volume":"5","author":"Scolaro","year":"2024","journal-title":"Nat Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114406","article-title":"P2Y receptors for extracellular nucleotides: contributions to cancer progression and therapeutic implications","volume":"187","author":"Woods","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114469","article-title":"Tumor-intrinsic P2RY6 drives immunosuppression by enhancing PGE2 production","volume":"43","author":"Xu","year":"2024","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2841","article-title":"A novel MIF signaling pathway drives the Malignant character of pancreatic cancer by targeting NR3C2","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgac092","article-title":"Dysregulation of HNF1B\/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients","volume":"43","author":"Yang","year":"2022","journal-title":"Carcinogenesis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S270326","article-title":"A nomogram for prediction of postoperative pneumonia risk in elderly hip fracture patients","volume":"13","author":"Xiang","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"B30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-024-01287-7","article-title":"Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis","volume":"16","author":"Kim","year":"2024","journal-title":"Genome Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-019-0195-y","article-title":"Single-cell RNA-seq highlights intra-tumoral heterogeneity and Malignant progression in pancreatic ductal adenocarcinoma","volume":"29","author":"Peng","year":"2019","journal-title":"Cell Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-019-13420-x","article-title":"Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer","volume":"10","author":"Xu","year":"2019","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08792-8","article-title":"Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis","volume":"641","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"Hyman DM. A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01157-1","article-title":"Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer","volume":"54","author":"Cui Zhou","year":"2022","journal-title":"Nat Genet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188409","article-title":"Roles of CA19\u20139 in pancreatic cancer: Biomarker, predictor and promoter","volume":"1875","author":"Luo","year":"2021","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e183617","DOI":"10.1001\/jamasurg.2018.3617","article-title":"International validation of the eighth edition of the american joint committee on cancer (AJCC) TNM staging system in patients with resected pancreatic cancer","volume":"153","author":"Van Roessel","year":"2018","journal-title":"JAMA Surg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.212","article-title":"Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)","volume":"115","author":"Vernerey","year":"2016","journal-title":"Br J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-12-171","article-title":"Elevated serum CA19\u20139 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study","volume":"12","author":"Dong","year":"2014","journal-title":"World J Surg Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03362-3","article-title":"Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival","volume":"31","author":"Varghese","year":"2025","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.016","article-title":"Fibroblasts in cancer: Unity in heterogeneity","volume":"186","author":"Chhabra","year":"2023","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2024-0082","article-title":"Potential role of ANGPTL4 in cancer progression, metastasis, and metabolism: a brief review","volume":"57","author":"Park","year":"2024","journal-title":"BMB Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1249\/MSS.0000000000001294","article-title":"Angiopoietin-like 4 enhances the proliferation and migration of tendon fibroblasts","volume":"49","author":"Jamil","year":"2017","journal-title":"Med Sci Sports Exercise"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.22038\/IJBMS.2023.69196.15077","article-title":"ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPAR\u03b3","volume":"26","author":"Zhu","year":"2023","journal-title":"Iran J Basic Med Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1124-8","article-title":"Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target","volume":"39","author":"Filippou","year":"2020","journal-title":"Oncogene"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155242","article-title":"Multiple pathophysiological roles of midkine in human disease","volume":"135","author":"Cai","year":"2020","journal-title":"Cytokine"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn6068","article-title":"Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease","volume":"10","author":"Srivastava","year":"2024","journal-title":"Sci Adv"},{"key":"B56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s42003-024-06154-0","article-title":"Midkine promotes renal fibrosis by stabilizing C\/EBP\u03b2 to facilitate endothelial-mesenchymal transition","volume":"7","author":"Xu","year":"2024","journal-title":"Commun Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00807-z","article-title":"Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms","volume":"5","author":"Chu","year":"2024","journal-title":"Nat Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2015.02.004","article-title":"Dependence of fibroblast infiltration in tumor stroma on type IV collagen-initiated integrin signal through induction of platelet-derived growth factor","volume":"1853","author":"Chen","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-016-0475-z","article-title":"MIF\/CD74 axis is a target for novel therapies in colon carcinomatosis","volume":"36","author":"Bozzi","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.160","article-title":"MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis","volume":"35","author":"Ghoochani","year":"2016","journal-title":"Oncogene"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1846915","article-title":"MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma","volume":"9","author":"De Azevedo","year":"2020","journal-title":"Oncoimmunology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13046-024-03024-9","article-title":"Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization","volume":"43","author":"Liu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150686","article-title":"Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer","volume":"733","author":"Zhang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41423-023-01110-0","article-title":"Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment","volume":"21","author":"Zheng","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00737-6","article-title":"T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours","volume":"5","author":"Lesch","year":"2021","journal-title":"Nat BioMed Eng"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01604-z","article-title":"CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer\u2019s disease pathology","volume":"24","author":"Su","year":"2023","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1900311","DOI":"10.1002\/adbi.201900311","article-title":"Suppressive myeloid cells shape the tumor immune microenvironment","volume":"5","author":"Xiong","year":"2021","journal-title":"Adv Biol (Weinh)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/bs.acc.2023.11.002","article-title":"Osteopontin in cancer","volume":"118","author":"Kumari","year":"2024","journal-title":"Adv Clin Chem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","article-title":"Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis","volume":"161","author":"Nallasamy","year":"2021","journal-title":"Gastroenterology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbcan.2017.02.005","article-title":"Osteopontin splice variants and polymorphisms in cancer progression and prognosis","volume":"1868","author":"Briones-Orta","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0483","article-title":"Oncostatin M receptor-targeted antibodies suppress STAT3 signaling and inhibit ovarian cancer growth","volume":"81","author":"Geethadevi","year":"2021","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.04.016","article-title":"Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms","volume":"120","author":"Avtanski","year":"2019","journal-title":"Cytokine"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207790","article-title":"An overview of ADAM9: structure, activation, and regulation in human diseases","volume":"21","author":"Chou","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788682415","article-title":"ADAM9 as a potential target molecule in cancer","volume":"15","author":"Peduto","year":"2009","journal-title":"Curr Pharm Des"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2796-x","article-title":"The pleiotropic roles of ADAM9 in the biology of solid tumors","volume":"75","author":"Oria","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00720-x","article-title":"Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy","volume":"5","author":"Huang","year":"2024","journal-title":"Nat Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0915","article-title":"Preclinical evaluation of IMGC936, a next-generation maytansinoid-based antibody-drug conjugate targeting ADAM9-expressing tumors","volume":"21","author":"Scribner","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165656","article-title":"CD36 and CD97 in pancreatic cancer versus other Malignancies","volume":"21","author":"Tanase","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.7150\/jca.21046","article-title":"Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis","volume":"9","author":"Jia","year":"2018","journal-title":"J Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101234","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","journal-title":"Cell Rep Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06073-w","article-title":"Uridine-derived ribose fuels glucose-restricted pancreatic cancer","volume":"618","author":"Nwosu","year":"2023","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308208","article-title":"Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","article-title":"Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis","volume":"15","author":"Liao","year":"2024","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.jid.2022.02.017","article-title":"P2RY6 has a critical role in mouse skin carcinogenesis by regulating the YAP and \u03b2-catenin signaling pathways","volume":"142","author":"Xu","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29779","article-title":"The P2Y6 receptor signals through G\u03b1q \/Ca2+ \/PKC\u03b1 and G\u03b113 \/ROCK pathways to drive the formation of membrane protrusions and dictate cell migration","volume":"235","author":"Girard","year":"2020","journal-title":"J Cell Physiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.02.008","article-title":"The G protein-coupled P2Y6 receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis","volume":"1864","author":"Placet","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708441\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:31:47Z","timestamp":1764138707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708441\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":89,"alternative-id":["10.3389\/fimmu.2025.1708441"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1708441","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1708441"}}